DAIC

FEBRUARY 26, 2025

a provider of AI technology for coronary artery disease (CAD) management, recently introduced its new brand identity reflecting its focus on delivering clarity, precision and confidence in the prevention, diagnosisand treatment of CAD. CAD is estimated to be responsible for one heart attack every 40 seconds and one out of every five deaths.

Coronary Artery Disease 59

Coronary Artery Disease Heart Attack Heart attacks Technology 59

DAIC

MAY 14, 2024

Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interventional cardiology portfolio built around the Allia Platform.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

DAIC

JULY 18, 2024

Elucid’s PlaqueIQ is the first and only histology-validated FDA-cleared software to non-invasively quantify and characterize non-calcified plaque and its components such as lipid-rich necrotic core (LRNC), giving potential insights into high-risk plaques, key drivers of risk of heart attack and stroke.

Plaque 105

Plaque Heart Attack Heart attacks Cardiovascular Disease 105

SoftCath

MAY 22, 2021

But as the new variants and their implications started showcasing in the infected patients, it became clear that it has several physiological manifestations. Do the healthcare clinics have the tools and technologies needed for diagnosing complicated heart conditions?

COVID-19 52

COVID-19 Blood Clot Technology Cardiovascular Disease 52